Join Us March 13th @ 1 pm ET BEFORE Nvidia’s “Q-Day”

In 2016 Louis Navellier made a big prediction regarding Nvidia’s GPUs... It went up more than 7,000% at its peak. Don’t miss Louis NEXT Nvidia call. (Plus 6 stocks you need to own before March 20th.)

Thu, March 13 at 10:00AM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

The Dividend Dominators: 3 Stocks That Will Make Your Portfolio Reign Supreme

By Faizan Farooque, InvestorPlace Contributor
Top dividend stocks across various sectors continue to reward investors, even as they face sales shortfalls and leadership changes.

Dividend Delights: 3 Stocks That Will Sweeten Your Investment Returns

By Faizan Farooque, InvestorPlace Contributor
Despite global risks, top dividend stocks like Prologis, AT&T, and Medtronic offer strong yields and growth potential.

3 Penny Stocks That Will Blast Higher on Meme Euphoria

By Faisal Humayun, InvestorPlace Contributor
These are the meme penny stocks to buy as they represent companies with impending growth catalysts and average fundamentals.

Canopy Growth Stock: This Pot Pick Could Hit $15 Sooner Than You Think

By David Moadel, InvestorPlace Contributor
Canopy Growth stock is definitely high-risk but also has strong growth potential as Canopy Growth steadily ramps up its revenue.

3 S&P 500 Stocks to Buy in June Before They Ascend to New Heights

By Terel Miles, InvestorPlace Contributor
The stock market is filled with promising opportunities. These three S&P 500 stocks to buy are gearing up for an explosive move in June.

Penny Stocks That Insiders Are Loading Up On: 3 Names to Watch Closely

By Ian Cooper, InvestorPlace Contributor
Penny stocks are risky. It’s why we attach a warning to the tail-end of penny stock articles and why the SEC has a warning about them too.

June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge

By Tezcan Gecgil, InvestorPlace Contributor
Biotech surge alert! Discover three biotech stocks to buy as they catch up with the market in the rest of 2024.

Farm Bill 2024: 3 Stocks That Would Get Smoked if Hemp Ban Passes

By Jeremy Flint, InvestorPlace Contributor
A hemp ban amendment to the 2018 Farm Bill seeks to close a loophole authorizing intoxicating hemp derivatives.

Buy Alert: 3 Penny Stocks That Will Explode in 2024

By Viktor Zarev, InvestorPlace Contributor
When the term penny stocks to buy is thrown around, ideas of high-risk-high-reward, overnight wealth generation and potential scams may come to mind. However, investing…

The 3 Most Undervalued Healthcare Stocks to Buy in June 2024

By Josh Enomoto, InvestorPlace Contributor
When it comes to seeking discounts, investors may do well with undervalued healthcare stocks. Primarily, that’s because with this sector, you’re dealing with a permanently…

Blue-Chip Behemoths: 3 Industry Giants Trading at Shockingly Low Prices

By Ian Bezek, InvestorPlace Contributor
These three undervalued blue-chip stocks are all trading for less than ten times forward earnings, offering great value today.

Why Is Avalon Globocare (ALBT) Stock Down 27% Today?

By William White, InvestorPlace Writer
Avalon Globocare stock is down on Tuesday as shares of ALBT pull back from a massive rally on Monday alongside a Form 10-Q filing.

Why Is Fresh2 Group (FRES) Stock Up 31% Today?

By William White, InvestorPlace Writer
Fresh2 Group stock is up on Tuesday with heavy pre-market trading of FRES shares despite a lack of news from the biotechnology company.

The 3 Most Undervalued Growth Stocks to Buy in June 2024

By Noah Bolton, InvestorPlace Contributor
Undervalued growth stocks are a perfect addition to a portfolio for investors looking for substantial returns.

The 3 Most Undervalued Under-$10 Stocks to Buy in June 2024

By Achintya Pasricha, InvestorPlace Contributor
These three, sub $10 stocks with enormous upside potential might just be your best investment nuggets this month.

The 3 Most Undervalued Biotech Stocks to Buy in June 2024

By Ian Cooper, InvestorPlace Contributor
Undervalued biotech stocks can offer some of the most explosive opportunities. That is, if you can spot the right one at the right time. Many…

7 High-Yield Dividend Stocks That Work While You Sleep

By Josh Enomoto, InvestorPlace Contributor
Although seemingly most of the celebrated ideas on financial publications center on high-growth plays, investors should spare some thought toward high-yield dividend stocks. In particular,…

3 High-Yield Dividend Stock Picks for Stellar Returns

By Yiannis Zourmpanos, InvestorPlace Contributor
Opportunities exist for astute investors looking for high-yield income and steady growth in today's changing financial environment.

GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.

By Chris MacDonald, InvestorPlace Contributor
Investors in GlaxoSmithKline are seeing a lot of red on their screens today, as GSK stock falls more than 8% on big legal news.
Load More Articles